DRUGS · SERVICE DETAILS

Registration and annual maintenance of pharmaceutical facilities

(b) Reconciling registration applicability with existing records around actual drug sites and operations and facilitating initial registration, annual renewal, change and transfer of records; Producting Listing is recognized separately from other obligations.

The registration of a facility does not amount to a FDA product approval, cGMP inspection pass or listing permit. The inclusion of U.S. agency services, product listing and other technical work should be identified separately.

SERVICE OVERVIEW

What does this service help with?

Align physical facilities, business information, DUNS, operations and offshore liaison arrangements, prepare for SPL application as agreed, process validation feedback and deliver submission and acceptance of records. Registers are already in place to verify historical versions, avoid duplication or replace production sites with headquarters.

WHO MAY NEED IT

Who should consider this service?

Facilities involving activities such as manufacturing, repackaging, relabelling or recycling of medicines for distribution in the United States and legally required to be registered, as well as enterprises responsible for coordinating information. Pure brands or trading agents need to be judged separately from actual activities.

SCOPE & APPROACH

What could be included in the registration and annual maintenance of pharmaceutical facilities?

The enterprises, products and existing records are checked before information responsibilities, delivery content and maintenance are defined.

01

Applied verification of sites and activities

The scope of registration and exceptions are checked against actual products, operations and sites, identifying the facilities that require separate processing and the records that are available.

02

Facilities identity check with DUNS data

Check name, actual address and corresponding location DUNS, collating discrepancies with historical records or Headquarters information, and follow-up information.

03

Offshore liaison and import documentation

Clear authorization and communication arrangements by collating FDA contacts, applying U.S. agents and known importers; Whether acting as an agent includes a separate confirmation.

04

First registration and feedback processing

Preparation for application of facility registration SPL as mandated, collaborative submission and checking of acceptance or error feedback, preservation of documents and pending matters.

05

Annual renewals and updates of changes

Review information in the application of the renewal window, distinguishing between change updates and no change notifications; Dismissals, write-offs, etc. are treated on a case-by-case basis.

06

Record handover and maintenance of listings

Hand-over version, acceptance results and query reconciliation records, alerting the facility to maintain the project list separately from the complete obligation to avoid renewal.

GET READY

What to prepare for the assessment

A summary of the project and a catalogue of existing records may be provided first, and detailed documents may be transferred to confidentiality arrangements as authorized.

  • Name, address and corresponding DUNS of the physical facility
  • Site activities, pharmaceutical types and United States distribution or import schemes
  • FDA contact, U.S. agent and known importer, etc.
  • Existing registration SPL, acceptance results and historical changes
  • Accounts Authority, Delegation of Authority and Information Manager
  • Existing product and facility correspondence and proposed processing
HOW TO START

From initial review to engagement

STEP 01

Reconciling facilities with existing records

Identification of scope of application, physical location and historical version, with data to be added.

STEP 02

Confirmation of information and division of labour

Check DUNS, activities, contacts, agents and imports, with clear scope and authorization.

STEP 03

Prepare to submit and follow up on feedback

SPL is prepared according to the applicable process, and the acceptance or error record is submitted and maintained after review.

STEP 04

Handover and arrangement maintenance

Reconciling public records, handing over documents and arranging for renewals, changes and product maintenance.

The registration of a facility does not amount to a FDA product approval, cGMP inspection pass or listing permit. The inclusion of U.S. agency services, product listing and other technical work should be identified separately.

TIMING & FEES

Timing and fees

Information reviewed:Period of application of costs: reconciliation of official rules: 2026-11-06; The applicable user fees are applied separately from the current fiscal year according to the specific activity.

Timing and preparation

Document preparation

Schedules based on the number of facilities, DUNS consistency, contact authorization and the integrity of historical records; Data discrepancies or systematic feedback require additional time.

FDA processing

(b) The offshore facilities have been registered before the medicines are to be imported; The annual renewal will take place from 1 October to 31 December of each year. Submission, acceptance and disclosure are not product approval procedures and there is no commitment of uniform approval days.

Fee breakdown

FDA fees

Registration of general pharmaceutical facilities and submission of Drug Listing does not in and of itself charge a fee; This does not amount to a total FDA obligation for the enterprise to be free of charge. Depending on the actual drug and facility activity, additional user fees are available for GDUFA, OMUFA, PDUFA or other applicable user fees.

Service fees

(a) Proposing proposals by number of facilities, first or renewal, data verification, updating and feedback processing scope; Whether U.S. agent, product listing and ongoing maintenance are listed separately.

Other possible costs

Translation, DUNS information verification, third-party work and other technical matters are listed separately according to actual arrangements; The applicable user fees are separately recognized according to the activities of the enterprise.

OFFICIAL SOURCES

Official basis of this service

Data check: 2026-11-06. Specific applicability and submission requirements should be identified in conjunction with real business.

START WITH YOUR PRODUCT

Starting with the product and the existing records.

Description of enterprise activities, products and available documentation, identification of information gaps, delivery, processing plans and quotations.